Traws Pharma, Inc.
TRAWNasdaqCIK 1130598HealthcareFiscal year ends Dec 31
Reports and events: 342 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2317:18 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-26-118519 |
| 2026-10-2016:05 ET | DEF 14A | Proxy statementPeriod 2026-12-03 | 0001104659-26-117406 |
| 2026-08-1416:35 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-097261 |
| 2026-08-1416:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-097226 |
| 2026-07-3116:15 ET | 8-K | 3.01 Delisting notice | 0001104659-26-089220 |
| 2026-07-1016:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-082649 |
| 2026-07-0916:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-082250 |
| 2026-06-2207:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-076058 |
| 2026-06-1217:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-073593 |
| 2026-05-2909:00 ET | DEF 14A | Proxy statementPeriod 2026-07-08 | 0001104659-26-067945 |
| 2026-05-2708:50 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-066623 |
| 2026-05-2617:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-066345 |
| 2026-05-1507:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-061779 |
| 2026-05-1507:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-061771 |
| 2026-05-0518:55 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000947871-26-000492 |
| 2026-04-3016:35 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001104659-26-053041 |
| 2026-04-1516:47 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-043832 |
| 2026-04-1516:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-043781 |
| 2026-04-1508:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-043497 |
| 2026-02-1908:42 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-017298 |
| 2026-01-2608:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-006460 |
| 2026-01-1307:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-003071 |
| 2025-12-1706:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-121749 |
| 2025-12-1617:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-121635 |
| 2025-11-2816:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-116962 |
| 2025-11-1307:30 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-110845 |
| 2025-11-1307:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-110829 |
| 2025-10-1717:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-100455 |
| 2025-10-1407:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-098994 |
| 2025-10-0816:16 ET | DEF 14A | Proxy statementPeriod 2025-11-21 | 0001104659-25-097926 |
| 2025-10-0607:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-096920 |
| 2025-09-1216:33 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001104659-25-089564 |
| 2025-08-1807:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-079454 |
| 2025-08-1407:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-078060 |
| 2025-08-1407:00 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011469 |
| 2025-07-0317:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-065842 |
| 2025-06-3006:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-063793 |
| 2025-06-0307:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-055709 |
| 2025-05-2708:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-052729 |
| 2025-05-1908:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-050242 |
| 2025-05-1516:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007872 |
| 2025-05-1507:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-048915 |
| 2025-04-3016:31 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001558370-25-006013 |
| 2025-04-1816:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-036366 |
| 2025-04-0717:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-032684 |
| 2025-03-3116:35 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-004165 |
| 2025-03-3109:21 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-029687 |
| 2025-03-2816:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-029405 |
| 2025-03-2507:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-027545 |
| 2025-03-2407:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-026854 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:48 ET. Listed shows no prices and gives no investment advice.